Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
+0.55%
3-Month Return
+9.93%
12-Month Return
+34.16%
Volatility Score
2.3
RSI
51.9
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $237B | +54.73% | +18.93% | +8.17% | 2.4 | Up | Up |
| GILD | Gilead Sciences | $193B | +32.21% | +19.91% | +3.09% | 2.4 | Up | Up |
| VRTX | Vertex Pharma | $133B | +24.33% | +10.75% | +1.47% | 2.4 | Neutral | Up |
| REGN | Regeneron Pharma | $83B | +40.00% | +23.63% | +0.40% | 2.8 | Neutral | Up |
| MRNA | MODERNA | $80B | +648.32% | +250.93% | +9.88% | 10.3 | Up | Up |
| NTRA | Natera | $58B | +109.83% | +52.61% | +3.37% | 4.3 | Up | Up |
| ARGX | arGEN-X SpADR | $55B | +6.90% | -5.50% | -7.62% | 3.7 | Down | Neutral |
| ONC | BeOne Medi Sp ADR | $43B | +21.50% | +15.56% | +3.46% | 2.8 | Up | Up |
| ILMN | Illumina | $41B | +169.12% | +36.86% | +5.50% | 5.4 | Up | Up |
| RVMD | REVOLUTION MEDIC | $40B | +243.23% | -0.93% | -1.97% | 5.0 | Down | Up |
| BIIB | Biogen | $37B | +67.25% | +24.96% | +10.18% | 2.7 | Up | Up |
| ALNY | Alnylam Pharma | $30B | -51.66% | -16.64% | -9.12% | 3.9 | Down | Down |
| GMAB | GENMAB SP ADR | $27B | +46.50% | +50.12% | +26.01% | 3.5 | Up | Up |
| ROIV | ROIVANT SCIENCES | $26B | +100.27% | +3.96% | -0.90% | 3.7 | Down | Up |
| UTHR | United Therapeut | $25B | +40.36% | +10.95% | +20.04% | 3.9 | Up | Up |
| INCY | Incyte | $23B | +26.76% | -0.84% | -7.16% | 2.8 | Down | Up |
| BNTX | BioNTech Sp ADR | $22B | -16.61% | -4.29% | -10.51% | 3.5 | Down | Down |
| INSM | Insmed | $20B | -41.51% | -13.05% | -21.08% | 4.4 | Down | Down |
| MEDP | Medpace Holdings | $19B | +10.57% | +10.46% | +8.43% | 3.3 | Up | Up |
| CRL | Charles Riv Lab | $16B | +75.28% | +50.63% | +24.53% | 3.8 | Up | Up |
| ASND | ASCENDIS PHARMA BR | $16B | +20.48% | -3.68% | +9.07% | 2.5 | Neutral | Neutral |
| EXEL | Exelixis | $16B | +66.66% | +15.96% | +13.75% | 2.5 | Up | Up |
| NBIX | Neurocrine Biosc | $15B | -0.90% | -18.06% | +2.30% | 2.6 | Down | Down |
| HALO | Halozyme Therape | $14B | +89.92% | +55.41% | +11.73% | 2.6 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $13B | +26.35% | -17.33% | +4.34% | 3.1 | Down | Down |
| SMMT | SUMMIT THERAP | $12B | -19.76% | +3.27% | -5.96% | 6.8 | Down | Down |
| TEM | TEMPUS AI-A | $12B | -24.22% | +46.96% | -11.72% | 8.7 | Down | Up |
| TECH | Bio-Techne | $11B | +10.71% | +1.20% | +0.04% | 0.2 | Neutral | Up |
| RGEN | Repligen | $11B | +6.37% | +28.58% | -4.12% | 5.1 | Down | Up |
| BMRN | Biomarin Pharm | $11B | +2.70% | -4.96% | -10.06% | 2.9 | Down | Down |
| MDGL | Madrigal Pharmct | $10B | +3.02% | -20.08% | -15.36% | 3.9 | Down | Down |
| PCVX | VAXCYTE | $9.5B | +43.10% | +8.61% | +6.97% | 8.2 | Down | Up |
| TXG | 10X GENOMICS-A | $9.3B | +419.61% | +48.88% | -5.38% | 9.8 | Down | Up |
| TWST | TWIST BIOSCIENCE | $9.3B | +310.20% | +51.36% | -11.72% | 10.9 | Down | Up |
| KRYS | KRYSTAL BIOTECH | $9.2B | +67.36% | -4.89% | -8.85% | 3.3 | Down | Neutral |
| KYMR | KYMERA THERAP | $9.2B | +89.14% | +0.34% | -4.08% | 4.6 | Down | Up |
| CAI | CARIS | $9B | +2.99% | +104.47% | +1.11% | 6.1 | Up | Up |
| PTGX | Protagonist Ther | $9B | +84.92% | +2.22% | -0.19% | 4.0 | Down | Up |
| BRKR | Bruker | $8.8B | +48.29% | -7.26% | -3.49% | 5.3 | Down | Up |
| IBRX | IMMUNITYBIO | $8.7B | +232.79% | +11.08% | -4.75% | 9.2 | Down | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |